Soen, Satoshi
Kaku, Miki
Okubo, Naoki
Onishi, Yoshie
Saito, Kengo
Kobayashi, Makiko
Funding for this research was provided by:
Daiichi-Sankyo
Article History
Received: 13 October 2021
Accepted: 8 March 2022
First Online: 11 May 2022
Declarations
:
: SS has received consulting fees, speaking fees or honoraria from Asahi Kasei Pharma, Astellas, Amgen, Daiichi Sankyo, Eli Lilly Japan, and UCB Japan. MKaku, NO and KS are employees of Daiichi Sankyo, a pharmaceutical company which markets medications for the treatment of osteoporosis. MKobayashi is a former employee of Daiichi Sankyo Co., Ltd. YO is an employee of Creativ-Ceutical, a consultancy company who received funding from Daiichi Sankyo for the implementation of this study.